GSTM1 and COVID-19: Abbas et al. found that in the North Indian population, GSTM1/GSTT1 polymorphism was not shown to have a significant association with the severity of COVID-19, but death was significantly higher in patients with the GSTT1 null genotype, and patients having GSTM1 wild/GSTT1 null genotypes showed a poor survival rate [14].